Antiplatelet agents for preventing pre-eclampsia and its complications
Access status:
Open Access
Type
ArticleAbstract
We set out to assess the ability of antiplatelet agents, such as aspirin and dipyridamole, to prevent women from developing pre-eclampsia during pregnancy and to improve health outcomes for them and their babies. We also wanted to find out whether these medicines had any undesirable effects for the mother or baby.We set out to assess the ability of antiplatelet agents, such as aspirin and dipyridamole, to prevent women from developing pre-eclampsia during pregnancy and to improve health outcomes for them and their babies. We also wanted to find out whether these medicines had any undesirable effects for the mother or baby.
See less
See less
Date
2019Publisher
Cochrane Database of Systematic ReviewsLicence
Copyright All Rights ReservedFaculty/School
Faculty of Medicine and Health, NHMRC Clinical Trials CentreShare